Aviva (OTCMKTS:AVVIY) Price Target Increased to GBX 545 by Analysts at JPMorgan Chase & Co.

Aviva (OTCMKTS:AVVIY – Get Rating) had its target price lifted by JPMorgan Chase & Co. from GBX 535 ($6.52) to GBX 545 ($6.64) in a research report report published on Monday, The Fly reports.

AVVIY has been the topic of a number of other research reports. Morgan Stanley decreased their price target on shares of Aviva from GBX 540 ($6.58) to GBX 520 ($6.34) in a research note on Wednesday, February 8th. Barclays decreased their price target on shares of Aviva from GBX 560 ($6.83) to GBX 545 ($6.64) in a research note on Friday. Investec downgraded shares of Aviva from a buy rating to a hold rating in a research note on Thursday, December 15th. Berenberg Bank increased their target price on shares of Aviva from GBX 540 ($6.58) to GBX 546 ($6.65) in a research note on Tuesday, January 31st. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of Aviva from GBX 485 ($5.91) to GBX 540 ($6.58) in a research note on Tuesday, January 10th. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of Hold and an average price target of $520.86.

Aviva Stock Down 3.4 %

Aviva stock opened at $10.34 on Monday. The firm’s fifty day moving average is $10.83 and its 200 day moving average is $10.26. Aviva has a 52-week low of $8.05 and a 52-week high of $15.96.

About Aviva

(Get Rating)

Aviva Plc is a holding company, which engages in the provision of long-term insurance and savings, general and health insurance, and fund management products and services. It operates through the following segments: United Kingdom and Ireland; Canada; France; Italy; Poland; and Other. The United Kingdom and Ireland segment offers risks associated with motor vehicles, property and liability, and medical expenses insurance cover to individuals and businesses.